Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Auto-generated profile, based on publicly available information
Yangbo Zhu
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
The therapeutic efficacy of hepatocellular carcinoma (HCC) medication is severely compromised by inadequate drug delivery to tumor sites. Herein, we fabric